Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric sulfate is a small molecule medication used primarily as a coagulant and hemostatic agent. It is a dark brown or yellow chemical compound with acidic properties, produced by the reaction of sulfuric acid and an oxidizing agent. Ferric sulfate acts by chemically interacting with blood proteins to promote coagulation and stop bleeding. It has been used in dermatology (notably as part of Monsel's solution for antihemorrhagic purposes during skin and mucosal biopsies), as well as in dentistry to control pulpal bleeding, serve as an antibacterial agent, and manage hemorrhage during dental procedures. While effective for hemostasis, its corrosive nature can cause tissue injury compared to alternatives like collagen[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric sulfate.